Author's reply to Borg et al. Comment on: "EU's new pharmacovigilance legislation: Considerations for biosimilars"

  1. Calvo, B.
Aldizkaria:
Drug Safety

ISSN: 1179-1942 0114-5916

Argitalpen urtea: 2014

Alea: 37

Zenbakia: 2

Orrialdeak: 125-126

Mota: Gutuna

DOI: 10.1007/S40264-013-0130-Y GOOGLE SCHOLAR